Marie Yurkovich

Chief Operating Officer at Oak Hill Bio Corp.

Finance

Commercial Services

Profile

Marie Yurkovich is currently the Vice President, Head-Strategy & Operations at Oak Hill Bio Corp.
Prior to this, she worked as an Associate at Vectr Ventures Ltd from 2019 to 2020.

Marie Yurkovich active positions

Companies	Position	Start
Oak Hill Bio Corp. Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA.	Chief Operating Officer	-

All active positions of Marie Yurkovich

Former positions of Marie Yurkovich

Companies	Position	End
Vectr Ventures Ltd Vectr Ventures Ltd Investment ManagersFinance Vectr Ventures Ltd is a venture capital firm founded in 2009 by Arthur Law, Alan Chan, Jason Best, Mark Munoz and Adrian Chan. The firm is headquartered in Hong Kong.	Private Equity Analyst	31/01/2020

See the detail of Marie Yurkovich's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Marie Yurkovich's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Vectr Ventures Ltd Vectr Ventures Ltd Investment ManagersFinance Vectr Ventures Ltd is a venture capital firm founded in 2009 by Arthur Law, Alan Chan, Jason Best, Mark Munoz and Adrian Chan. The firm is headquartered in Hong Kong.	Finance
Oak Hill Bio Corp. Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA.	Commercial Services